Gates Foundation commits $120 million to accelerate access to COVID-19 drug for lower-income countries
Sierra Leone Telegraph: 20 October 2021: The Bill & Melinda Gates Foundation announced today a commitment of up to $120 million to accelerate access to the investigational antiviral drug molnupiravir for lower-income countries as part of its COVID-19 response effort. The funding will be allocated based on consultations with partners, [Read More]